PYSZCZYMUKA GREG 4
4 · AYTU BIOPHARMA, INC · Filed Oct 7, 2025
Insider Transaction Report
Form 4
PYSZCZYMUKA GREG
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-10-03+12,500→ 36,102 total
Footnotes (1)
- [F1]Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027.